The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostatic Powders and Hemostatic Agents Market Research Report 2024
Synopsis
Hemostatic powders and hemostatic agents are medical products used to control bleeding or promote hemostasis (the process of stopping bleeding) in various clinical settings. These products are designed to aid in the management of bleeding in situations where conventional methods such as pressure, sutures, or cauterization may be insufficient or impractical.
Global Hemostatic Powders and Hemostatic Agents market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemostatic Powders and Hemostatic Agents market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hemostatic Powders and Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Novartis
Anika Therapeutics
Advanced Medical Solutions
Segment by Type
Microfibrous Collagen
Chitosan
Segment by Application
Home
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemostatic Powders and Hemostatic Agents report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Hemostatic powders and hemostatic agents are medical products used to control bleeding or promote hemostasis (the process of stopping bleeding) in various clinical settings. These products are designed to aid in the management of bleeding in situations where conventional methods such as pressure, sutures, or cauterization may be insufficient or impractical.
Global Hemostatic Powders and Hemostatic Agents market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hemostatic Powders and Hemostatic Agents market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hemostatic Powders and Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Novartis
Anika Therapeutics
Advanced Medical Solutions
Segment by Type
Microfibrous Collagen
Chitosan
Segment by Application
Home
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hemostatic Powders and Hemostatic Agents report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microfibrous Collagen
1.2.3 Chitosan
1.3 Market by Application
1.3.1 Global Hemostatic Powders and Hemostatic Agents Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Home
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemostatic Powders and Hemostatic Agents Market Perspective (2018-2029)
2.2 Hemostatic Powders and Hemostatic Agents Growth Trends by Region
2.2.1 Global Hemostatic Powders and Hemostatic Agents Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemostatic Powders and Hemostatic Agents Historic Market Size by Region (2018-2023)
2.2.3 Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Region (2024-2029)
2.3 Hemostatic Powders and Hemostatic Agents Market Dynamics
2.3.1 Hemostatic Powders and Hemostatic Agents Industry Trends
2.3.2 Hemostatic Powders and Hemostatic Agents Market Drivers
2.3.3 Hemostatic Powders and Hemostatic Agents Market Challenges
2.3.4 Hemostatic Powders and Hemostatic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue
3.1.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue (2018-2023)
3.1.2 Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Players (2018-2023)
3.2 Global Hemostatic Powders and Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemostatic Powders and Hemostatic Agents Revenue
3.4 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio
3.4.1 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemostatic Powders and Hemostatic Agents Revenue in 2022
3.5 Hemostatic Powders and Hemostatic Agents Key Players Head office and Area Served
3.6 Key Players Hemostatic Powders and Hemostatic Agents Product Solution and Service
3.7 Date of Enter into Hemostatic Powders and Hemostatic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemostatic Powders and Hemostatic Agents Breakdown Data by Type
4.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Type (2018-2023)
4.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Type (2024-2029)
5 Hemostatic Powders and Hemostatic Agents Breakdown Data by Application
5.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Application (2018-2023)
5.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
6.2 North America Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2018-2023)
6.4 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
7.2 Europe Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2018-2023)
7.4 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
8.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2018-2023)
8.4 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
9.2 Latin America Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2018-2023)
9.4 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
10.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2018-2023)
10.4 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Hemostatic Powders and Hemostatic Agents Introduction
11.1.4 BD Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.1.5 BD Recent Development
11.2 Medline Industries
11.2.1 Medline Industries Company Detail
11.2.2 Medline Industries Business Overview
11.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Introduction
11.2.4 Medline Industries Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.2.5 Medline Industries Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Hemostatic Powders and Hemostatic Agents Introduction
11.3.4 Baxter Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.3.5 Baxter Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Introduction
11.4.4 Pfizer Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Detail
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Introduction
11.5.4 Zimmer Biomet Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.5.5 Zimmer Biomet Recent Development
11.6 McKesson
11.6.1 McKesson Company Detail
11.6.2 McKesson Business Overview
11.6.3 McKesson Hemostatic Powders and Hemostatic Agents Introduction
11.6.4 McKesson Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.6.5 McKesson Recent Development
11.7 Integra Life Sciences
11.7.1 Integra Life Sciences Company Detail
11.7.2 Integra Life Sciences Business Overview
11.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Introduction
11.7.4 Integra Life Sciences Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.7.5 Integra Life Sciences Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Detail
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Introduction
11.8.4 Medtronic Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.8.5 Medtronic Recent Development
11.9 CryoLife
11.9.1 CryoLife Company Detail
11.9.2 CryoLife Business Overview
11.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Introduction
11.9.4 CryoLife Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.9.5 CryoLife Recent Development
11.10 CSL Behring
11.10.1 CSL Behring Company Detail
11.10.2 CSL Behring Business Overview
11.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Introduction
11.10.4 CSL Behring Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.10.5 CSL Behring Recent Development
11.11 Ethicon
11.11.1 Ethicon Company Detail
11.11.2 Ethicon Business Overview
11.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Introduction
11.11.4 Ethicon Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.11.5 Ethicon Recent Development
11.12 B Braun Melsungen
11.12.1 B Braun Melsungen Company Detail
11.12.2 B Braun Melsungen Business Overview
11.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Introduction
11.12.4 B Braun Melsungen Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.12.5 B Braun Melsungen Recent Development
11.13 Gelita Medical
11.13.1 Gelita Medical Company Detail
11.13.2 Gelita Medical Business Overview
11.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Introduction
11.13.4 Gelita Medical Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.13.5 Gelita Medical Recent Development
11.14 Smith & Nephew
11.14.1 Smith & Nephew Company Detail
11.14.2 Smith & Nephew Business Overview
11.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Introduction
11.14.4 Smith & Nephew Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.14.5 Smith & Nephew Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Detail
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Introduction
11.15.4 Teleflex Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.15.5 Teleflex Recent Development
11.16 Novartis
11.16.1 Novartis Company Detail
11.16.2 Novartis Business Overview
11.16.3 Novartis Hemostatic Powders and Hemostatic Agents Introduction
11.16.4 Novartis Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.16.5 Novartis Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Detail
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Introduction
11.17.4 Anika Therapeutics Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.17.5 Anika Therapeutics Recent Development
11.18 Advanced Medical Solutions
11.18.1 Advanced Medical Solutions Company Detail
11.18.2 Advanced Medical Solutions Business Overview
11.18.3 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Introduction
11.18.4 Advanced Medical Solutions Revenue in Hemostatic Powders and Hemostatic Agents Business (2018-2023)
11.18.5 Advanced Medical Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
